About CrossPoint Therapeutics
CrossPoint Therapeutics is a therapeutics company that specializes in drug development by using Stealth-Body antibody source technology.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Giheung, South Korea
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
crosspointrx.com
Domain Registered Date
Sep 28, 2022
Social & Network Presence
X / Twitter Profile
@ko
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Seed announced
- Milestone
Website domain registered
crosspointrx.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for CrossPoint Therapeutics.
Funding History
Seed equity
· Mar 4, 2026
Undisclosed
Founders & Leadership
Tae-erk Kim
Founder
Work email & phone locked
Unlock →
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026